全文获取类型
收费全文 | 644篇 |
免费 | 55篇 |
国内免费 | 17篇 |
专业分类
耳鼻咽喉 | 8篇 |
儿科学 | 38篇 |
妇产科学 | 7篇 |
基础医学 | 73篇 |
口腔科学 | 58篇 |
临床医学 | 66篇 |
内科学 | 106篇 |
皮肤病学 | 16篇 |
神经病学 | 37篇 |
特种医学 | 97篇 |
外科学 | 72篇 |
综合类 | 30篇 |
预防医学 | 25篇 |
眼科学 | 7篇 |
药学 | 46篇 |
中国医学 | 1篇 |
肿瘤学 | 29篇 |
出版年
2023年 | 5篇 |
2022年 | 4篇 |
2020年 | 5篇 |
2019年 | 6篇 |
2018年 | 13篇 |
2017年 | 10篇 |
2016年 | 14篇 |
2015年 | 11篇 |
2014年 | 7篇 |
2013年 | 20篇 |
2012年 | 21篇 |
2011年 | 26篇 |
2010年 | 25篇 |
2009年 | 34篇 |
2008年 | 15篇 |
2007年 | 37篇 |
2006年 | 6篇 |
2005年 | 12篇 |
2004年 | 14篇 |
2003年 | 23篇 |
2002年 | 13篇 |
2001年 | 10篇 |
2000年 | 14篇 |
1999年 | 10篇 |
1998年 | 23篇 |
1997年 | 39篇 |
1996年 | 32篇 |
1995年 | 18篇 |
1994年 | 18篇 |
1993年 | 19篇 |
1991年 | 8篇 |
1990年 | 4篇 |
1989年 | 20篇 |
1988年 | 21篇 |
1987年 | 16篇 |
1986年 | 22篇 |
1985年 | 22篇 |
1984年 | 11篇 |
1983年 | 13篇 |
1982年 | 8篇 |
1981年 | 12篇 |
1980年 | 9篇 |
1979年 | 6篇 |
1978年 | 5篇 |
1977年 | 5篇 |
1976年 | 4篇 |
1975年 | 3篇 |
1970年 | 3篇 |
1969年 | 4篇 |
1966年 | 5篇 |
排序方式: 共有716条查询结果,搜索用时 265 毫秒
1.
2.
The role of growth factors and cytokines in the impaired healing of chronic leg ulcers remains uncertain. The aim of this study was to determine whether changes in the amount and location of cytokines and growth factors may be associated with impaired healing in chronic leg ulcers. Biopsies from leg ulcers of 21 patients and from normal skin of nine healthy volunteers were examined immunohistochemically for selected growth factors and cytokines. Greater staining intensity was found in keratinocytes at the edges of ulcers compared to normal skin, or skin adjacent to the ulcers. Staining at the ulcer edge was more intense in nonhealing ulcers for only vascular endothelial growth factor and platelet-derived growth factor, whereas staining in the adjacent skin was more intense for all factors in the nonhealing phase. For all factors staining was cytoplasmic, suggesting production in these areas. This study shows up-regulation of the production of cytokines and growth factors in keratinocytes of chronic leg ulcers that is greater when the ulcers are nonhealing. 相似文献
3.
4.
5.
6.
7.
Trauma poses the greatest medical problem for the adolescent in terms of morbidity, mortality, and years of productive life lost. The emergency physician caring for the adolescent trauma patient must consider physical and intellectual changes that occur during this period of life. Clinicians must be familiar with both the approach to the traumatized child as well as the adult, and decide on the apropriate approach to the individual adolescent. The emergency physician is also in a position to support greater preventive measures by continued contributions to trauma surveillance, and by serving as a spokesperson and educator about adolescent injuries. 相似文献
8.
9.
10.
Picotamide inhibition of excess in vitro thromboxane B2 release by colorectal mucosa in inflammatory bowel disease. 总被引:1,自引:0,他引:1
Collins CE Benson MJ Burnham WR Rampton DS 《Alimentary pharmacology & therapeutics》1996,10(3):315-320
BACKGROUND: Inflammatory bowel disease is associated with increased mucosal release of eicosanoids. Among these, thromboxane A2 has been proposed as a possible inflammatory mediator; its suppression may be a useful therapeutic option. METHODS: Using a tissue incubation technique, we compared release of immunoreactive thromboxane B2 by colonic biopsies from patients with ulcerative colitis, Crohn's disease and controls, and assessed the inhibitory effect of picotamide, a thromboxane synthesis inhibitor-receptor antagonist, which has been widely used in Italy for management of ischaemic heart and cerebrovascular disease. RESULTS: Increased amounts of thromboxane B2 were released from biopsies from patients with active ulcerative colitis (median 238 pg/20 min/mg wet weight (interquartile range 147- 325), n = 12) and active Crohn's disease (252 (174-450), 6) compared with those from patients with quiescent ulcerative colitis (95 (61- 140), 12) or Crohn's disease (105 (57-201), 13), or controls (136 (64- 206), 8). Incubation with picotamide at concentrations between 100 microM and 1 mM reduced thromboxane B2 release (IC50 890 microM). CONCLUSION: Since increased thromboxane A2 production may have pathogenetic importance, thromboxane synthesis inhibitor-receptor antagonists such as picotamide merit therapeutic trial in the management of inflammatory bowel disease. 相似文献